Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

High-risk human papillomaviruses (HPVs) have been associated to the development of cervical and some other human cancers. Most of them express E6 and E7 oncoproteins, able to bind to p53 and retinoblastoma (pRb) tumor suppressor proteins respectively and neutralize their function. Restoration of these pathways by blocking E6 and E7 expression would provide a selective therapeutic effect. Here, we show that a clinically approved antiviral agent Cidofovir reduced E6 and E7 expression in cervical carcinoma Me180 and head and neck squamous cell carcinoma HEP2 cells at the transcriptional level. Cidofovir induced the accumulation of active p53 and pRb associated to induction of cyclin dependent kinase inhibitor p21(WAF1/CIP1) in Me180 and HEP2 cells. p53 induction was also shown in Hela HPV-positive cervical carcinoma cell line. In addition, S phase cell cycle accumulation with concomitant decrease of cyclin A expression were associated to the antiproliferative activity of Cidofovir in HPV-treated cells. Combining Cidofovir to irradiation both in vivo and in nude mice xenografts resulted in a marked radiosensitization in HPV-positive cells, which was not observed in virus negative cells. This study provides the basis for a new anticancer strategy to enhance the antitumor effect of ionizing radiation in HPV-related cancers, without increase deleterious effects.

Original publication

DOI

10.1038/sj.onc.1205006

Type

Journal article

Journal

Oncogene

Publication Date

04/04/2002

Volume

21

Pages

2334 - 2346

Keywords

Animals, Antiviral Agents, Carcinoma, Cell Division, Cyclin A, Cyclin-Dependent Kinase Inhibitor p21, Cyclins, Cytosine, Female, Head and Neck Neoplasms, Humans, Mice, Mice, Nude, Oncogene Proteins, Viral, Organophosphonates, Organophosphorus Compounds, Papillomaviridae, Papillomavirus Infections, Radiation, Ionizing, Radiation-Sensitizing Agents, Retinoblastoma Protein, Tumor Cells, Cultured, Tumor Suppressor Protein p53, Tumor Virus Infections, Uterine Cervical Neoplasms, Xenograft Model Antitumor Assays